Manulife (Manufacturers Life Insurance)’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.3K Sell
33,204
-1,635
-5% -$1.53K ﹤0.01% 2791
2025
Q4
$54K Sell
34,839
-3,038
-8% -$4.85K ﹤0.01% 2805
2025
Q3
$59.8K Sell
37,877
-324
-0.8% -$563 ﹤0.01% 2863
2025
Q2
$83.3K Sell
38,201
-1,123
-3% -$2.72K ﹤0.01% 2799
2025
Q1
$107K Sell
39,324
-1,174
-3% -$4.63K ﹤0.01% 2676
2024
Q4
$168K Sell
40,498
-539
-1% -$2.04K ﹤0.01% 2684
2024
Q3
$160K Sell
41,037
-1,252
-3% -$5.28K ﹤0.01% 2745
2024
Q2
$166K Buy
42,289
+8,454
+25% +$36.4K ﹤0.01% 2674
2024
Q1
$142K Sell
33,835
-715
-2% -$3.36K ﹤0.01% 2698
2023
Q4
$162K Hold
34,550
﹤0.01% 2693
2023
Q3
$108K Hold
34,550
﹤0.01% 2781
2023
Q2
$159K Buy
34,550
+1,249
+4% +$5.74K ﹤0.01% 2693
2023
Q1
$165K Hold
33,301
﹤0.01% 2630
2022
Q4
$182K Sell
33,301
-616
-2% -$3.78K ﹤0.01% 2613
2022
Q3
$220K Sell
33,917
-763
-2% -$4.26K ﹤0.01% 2522
2022
Q2
$164K Sell
34,680
-25,333
-42% -$125K ﹤0.01% 2747
2022
Q1
$419K Buy
60,013
+14,505
+32% +$99K ﹤0.01% 2301
2021
Q4
$470 Buy
+45,508
New +$489K ﹤0.01% 2302

Other funds holding MXCT

Manulife (Manufacturers Life Insurance)'s MXCT Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its MaxCyte (MXCT) stake by 4.7% in Q1 2026, selling an estimated $1.53K and leaving 33,204 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2791.

Manulife (Manufacturers Life Insurance) first reported a position in MXCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $419K in Q1 2022. 131 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 33,204 shares of MaxCyte worth $23.3K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,635 MaxCyte shares in Q1 2026, an estimated $1.53K.
  • MaxCyte made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2791 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in MaxCyte in Q4 2021 and has held it in 18 quarters since.
  • Manulife (Manufacturers Life Insurance)'s MaxCyte position peaked at $419K in Q1 2022.
  • 131 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.